{
    "Trade/Device Name(s)": [
        "ARK\u2122M Topiramate Assay",
        "ARKTM Topiramate Calibrator",
        "ARKTM Topiramate Control"
    ],
    "Submitter Information": "ARK Diagnostics, Inc.",
    "510(k) Number": "K083799",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070645",
        "K970509",
        "K970517"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NWM",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "April 3, 2009",
    "Summary Letter Received Date": "April 6, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3350",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin Test System"
    ],
    "Analyte Class(es)": [
        "tdm",
        "chemistry"
    ],
    "Analyte(s)": [
        "Topiramate"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARK Diagnostics ARK Topiramate Assay, Calibrator, and Control for quantitative measurement of topiramate in serum/plasma using homogeneous enzyme immunoassay on automated chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of topiramate in human serum or plasma for diagnosis and treatment of overdose and therapeutic monitoring; calibrator for assay calibration; control for assay quality control",
    "fda_folder": "Toxicology"
}